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The genus Ambelania (family Apocynaceae) is distributed
mainly over tropical South America. Plants of the Apocyna-
ceae family are rich sources of structurally diversiﬁed indole
alkaloids (Dewick, 2002).
A number of tropical plants were reported to elaborate
alkaloids with biological activity against tropical diseases6 50 500096687.
(S.-E. N. Ayyad).
y. Production and hosting by
Saud University.
lsevier
ND license.caused by protozoan parasites, including leishmaniasis,
Chaga’s disease, African trypanosomiasis (sleeping sick-
ness), and malaria (Osorio et al., 2008), which encouraged
us to investigate one of these plants Ambelania
occidentalis.
A. occidentalis is routinely used in folk medicine for treat-
ing gastrointestinal disorders, even though there have been
no safety trials, the genotoxicity potential of hydro-alcoholic
extracts of this plant in mice was assesed; induced DNA
damage was assessed in peripheral blood leucocytes and
micronucleus induction was assessed in polychromatic eryth-
rocytes from bone marrow (Castro et al., 2009). Indole alka-
loids have been extensively investigated for a wide variety of
pharmacological effects, such as anti-cancer (anti-tumour),
anti-HIV, anti-inﬂammatory, anti-leshmanial activity, anti-
malarial, contraceptive, bactericide, anti-hypertensive, central
nervous system stimulant (CNS) and anti-addiction agents
(Kam et al., 2004; Henriques et al., 1996; Carlini, 2003;
Maisonneuve and Glick, 2003). In this article, we report
the isolation and structure elucidation of two indole alka-
loids from A. occidentalis.
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2.1. Apparatus and methods
1D and 2D nuclear magnetic resonance spectra were recorded
on a Varian VI-500 MHz spectrometer for 1H NMR and a
Varian VI-300 MHz 1H NMR or Bruker WM 400 MHz spec-
trometers. Chemical shifts are given in (ppm) relative to TMS
as the internal standard. Electron impact mass spectra were
determined at 70 eV on a kratos MS-25 instrument. Thin layer
chromatography silica gel was used. Preparative thin layer
chromatography (PTLC) was performed on silica gel (kieselgel
60, F254).
2.2. Plant material
The plant A. occidentalis was collected from Amazon rainfor-
ests and identiﬁed by Botany group in Minnesota University,
Minnesota, USA. Voucher sample is deposited at the Chemis-
try Department, Faculty of science, King Abdulaziz Univer-
sity, Jeddah, Saudi Arabia.
2.3. Extraction and isolation
Extraction of the dried aerial parts (200 g) by methanol (400–
800 ml) was carried out three times at room temperature. The
extracts were combined and concentrated under reduced pres-
sure to obtain a dark brown residue (20.1 g, 10% of the dry
weight of the plant). The crude extract was acidiﬁed using
0.5 N HCl solution and extracted with diethyl ether to remove
the non-basic compounds. The aqueous phase was then made
alkaline with NaHCO3 and extracted with chloroform to re-
move the basic compounds, and the chloroform layer dried
over anhydrous sodium sulphate and evaporated under re-
duced pressure to yield the crude alkaloid fraction (1.5 g,
0.75% dry wt.). This crude fraction was chromatographed
on a silica gel column (60 g, 40 · 1.5 cm) and eluted succes-
sively with chloroform, chloroform–ethyl acetate, and chloro-
form–methanol. Fractions of 50 ml were collected, followed
by TLC on silica-gel plates, with Dragendorff’s reagent spray
used for visualisation. Promising fractions were further puri-
ﬁed by preparative thin layer silica gel chromatography
(PTLC), using the appropriate solvent system. Fractions eluted
by chloroform/ethylacetate (9.5:0.5) afforded substance 1 at Rf
0.67. Increasing the polarity to chloroform/methanol (9.2:0.8),
afforded substance 2 at Rf 0.43.
Vincamine ( 1): white solid (20 mg, 0.01% dry weight):
EIMS (probe) 70 eV, m/z (rel. int.): 354 (47) [M,
C21H26N2O3]
+, 307 (88) [MH2OC2H5]+, 266 (100), 224
(32), 168 (20); HREIMS Obsd. m/z = 354.1954 [M,
C21H26N2O3]
+ requires m/z = 354.1943; 1H NMR (CDCl3):
d 7.49 [1H, dd, J= 5.7, 3.0 Hz, H-9], 7.15 [1H, ddd,
J= 6.9, 5.9, 3.8 Hz, H-10], 7.14 [1H, ddd, J= 6.9, 5.0,
3.0 Hz, H-11], 7.10 [1H, dd, J= 5.6, 3.6 Hz, H-12], 4.62
[1H, br s, OH], 3.83 [3H, s, OMe], 3.64 [1H, m, H-3], 3.39
[1H, ddd, J= 13.7, 5.6, 2.8 Hz, H-5], 3.32 [1H, ddd,
J= 13.6, 8.0, 3.5 Hz, H-50], 3.00 [1H, ddd, J= 16.4, 7.8,
2.8 Hz, H-6], 2.69 [1H, m, H-19], 2.58 [1H, ddd, J= 16.4,
4.7, 3.2 Hz, H-60], 2.34 [1H, m, H-190], 2.32 [1H, dq,
J= 14.2, 7.3 Hz, H-20], 2.24 [1H, d, J= 14.5 Hz, Ha-15],
2.15 [1H, d, J= 14.4 Hz, Hb-15], 1.83 [1H, m, H-18], 1.67[1H, m, H-17], 1.49 [1H, ddq, J= 14.1, 6.8 Hz, H-200], 1.49
[1H, m, H-170], 1.43 [1H, m, H-180], 0.92 [3H, t, J= 7.5 Hz,
H-21]; 13C NMR (CDCl3) and H–H COSY are shown in Table
1.
14-epi-vincamine (2): Yellowish white solid (8 mg, 0.004%
dry weight): EIMS (probe) 70 eV, m/z (rel. int.): 354 (10) [M,
C21H26N2O3]
+, 336 (30) [M+H2O], 307 (69)
[MH2OC2H5]+, 266 (100); HREIMS Obsd. m/
z = 354.1962 [M, C21H26N2O3]
+ requires m/z = 354.1943;
1H NMR (CDCl3): d 7.44 [1H, dd, J= 5.8, 3.1 Hz, H-9],
7.32 [1H, dd, J= 5.3, 2.9 Hz, H-12], 7.13 [1H, ddd, J= 8.1,
5.8, 2.7 Hz, H-11], 7.12 [1H, ddd, J= 7.2, 5.8, 2.7 Hz, H-
10], 3.92 [1H, m, H-3], 3.73 [3H, s, OMe], 3.64 [1H, s, OH],
3.28 [1H, ddd, J= 13.4, 6.4, 4.6 Hz, H-5], 3.16 [1H, ddd,
J= 13.6, 7.9, 2.5 Hz, H-50], 2.93 [1H, ddd, J= 11.6, 6.2,
2.5 Hz, H-6], 2.60 [1H, d, J= 14.8 Hz, Hb-15], 2.51 [1H, m,
H-19], 2.48 [1H, ddd, J= 11.3, 7.6, 4.0 Hz, H-60], 2.19 [1H,
dq, J= 14.3, 7.5 Hz, H-20], 2.08 [1H, d, J= 14.9 Hz, Ha-
15], 2.04 [1H, m, H-190], 1.72 [1H, m, H-18], 1.46 [1H, ddq,
J= 14.2, 7.2 Hz, H-200], 1.32 [1H, m, H-17], 1.25 [2H, m, H-
170, H-180]; 13C NMR (CDCl3) and H–H COSY are shown
in Table 1.
3. Results and discussion
Chromatographic separation of the extract of A. occidentalis
afforded two indole alkaloids (1 and 2).
Compound 1 gave M+ at m/z 354, in accordance with
C21H26N2O3. The
13C NMR spectrum (Table 1) gave a total
of 21 separate signal carbon resonances and DEPT spectrum
showed two methyl, seven methylene, ﬁve methine and seven
quaternary carbons in agreement with the suggested molecular
formula, in addition, the presence of methyl ester was con-
ﬁrmed by signals at d 173.9 and 53.9 for carbonyl and methoxy
groups, respectively. Also the C-14 showed a signal at d 81.3
due to carbinol carbon.
The 1H NMR spectrum showed signiﬁcant signals charac-
teristic for four aromatic methine protons of the indole system
at d 7.49 (1H, dd, J= 5.7, 3.0 Hz, H-9), 7.15 (1H, ddd,
J= 6.9, 5.9, 3.8 Hz, H-10), 7.14 (1H, ddd, J= 6.9, 5.0,
3.0 Hz, H-11), 7.10 (1H, dd, J= 5.6, 3.6 Hz, H-12), the 1H
NMR also showed a methyl ester group at d 3.83 (3H, s).
The H–H COSY and HSQC spectral data revealed in addition
to the aromatic protons, three fragments CH2CH2N,
NCH2CH2CH2 and an isolated aminomethine, corresponding
to the C(6)–C(5), C(19)–C(18)–C(17) and C(3), respectively.
The CH2CH2N fragment is branched from the aromatic C-7
as indicated by the observed three-bond correlation from C-2
to H-6 in the HMBC spectrum. The NCH2CH2CH2 fragment
was deduced by H–H COSY and correlation between C-16
with H-17 and 18. The aminomethine C-3 was expected from
the correlation between C-2 and H-3 by HMBC spectrum.
The location of a methyl ester and hydroxy group at C-14
was expected from 13C NMR, DEPT spectrum and correlation
from methylene hydrogen H-15 to C-14 in HMBC. The substi-
tuent, ethyl side chain C(20)–C(21) at d 2.32, 1.49 and 0.92
attachment to C-16 was deduced by the long range coupling
between H-20 to H-3 from H–H COSY.
As the compound contains four double bonds of indole and
one carbonyl group, also the compound has ten degrees of
unsaturation from molecular formula C21H26N2O3, so the
Table 1 13C NMR data of compounds 1 and 2, including results of H–H COSY.
1
N
N
MeO2C
HO
H
H
2 3
5
67
9
10
11
14
15
16
17
19
20
21
2
N
N
HO
MeO2C
H
H
2 3
5
67
9
10
11
1415 1617
19
20
21
.
Carbon No. Compd. No.
1 2
dC DEPT H–H COSY dC DEPT H–H COSY
2 131.4 s – 130.9 s –
3 58.7 d – 58.3 d –
5 50.3 t 50, 6, 60 50.5 t 50, 6, 60
50 – – 5, 6, 60 – – 5, 6, 60
6 16.2 t 5, 50, 60 16.1 t 5, 50, 60
60 – – 5, 50, 6 – – 5, 50, 6
7 105.3 s – 105.7 s –
8 128.3 s – 128.0 s –
9 118.1 d 10, 11 117.7 d 10, 11
10 119.9 d 9, 11, 12 119.8 d 9, 11, 12
11 121.5 d 9, 10, 12 121.2 d 9, 10, 12
12 109.9 d 10, 11 111.5 d 10, 11
13 133.8 s – 134.9 s –
14 81.3 s – 82.1 s –
150 43.8 t 150 44.1 t 150
15 – – 15 – – 15
16 34.7 s – 35.9 s –
17 24.3 t 170, 18, 180 23.8 t 170, 18, 180
170 – – 17, 18, 180 – – 17, 18, 180
18 19.9 t 17, 170, 180, 19, 190 20.2 t 17, 170, 180, 19, 190
180 – – 17, 170, 18, 19, 190 – – 17, 170, 18, 19, 190
19 44.0 t 18, 180, 190 46.6 t 18, 180, 190
190 – – 18, 180, 19 – – 18, 180, 19
20 28.3 t 200, 21 28.5 t 200, 21
200 – – 20, 21 – – 20, 21
21 7.1 q 20, 200 7.1 q 20, 200
C‚O 173.9 s – 172.3 s –
OMe 53.9 q – 53.0 q –
OH – – – – – –
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the above results and the literature data (Schlittler and
Furlenmeier, 1953; Cordell et al., 2001) the compound 1 was
assigned as Vincamine.
Compound 2 spectral data (1H and 13C NMR) are closely
similar to those of compound 1, only a signiﬁcant difference
between both molecules could be rationalized in terms of 2
being the 14-epimar of compound 1. Speciﬁcally, the difference
between compound 1 and 2 was deduced from the deshielding
of carboxy ester group on the 1H NMR of H-12 at d 7.10 of 1
to 7.32 of 2 and 13C NMR of C-12, C-13, C-14 at d 109.9,
133.8, 81.3 of 1 to 111.5, 134.9, 82.1 of 2, respectively. So
the two structures are Vincamine (1) and 14-epi-vincamine
(2) (Atta-ur-Rahman and Sultana, 1984). The two metabolites
are known products from other plants and isolated here for the
ﬁrst time.4. Conclusion
The tropical South America plant A. occidentalis is a proliﬁc
source of indole alkaloids of high medicinal importance. The
two indole alkaloids Vincamine (1) and 14-Epivincamine (2)
were identiﬁed here for the ﬁrst time together from this plant,
although they were identiﬁed separately from plants of the
family Apocynaceae.Acknowledgments
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